II. Background

  1. Planned release 2018 in U.S.

III. Mechanism

IV. Efficacy

  1. Limits progression of bleeding within 12 hours of dose (onset as early as 1 hour)

V. Adverse Effects

  1. Expensive: $25,000 to 50,000 per patient
  2. Risk of Hypercoagulability complications (CVA, VTE)

VI. References

  1. (2018) Presc Lett 25(7): 37-8

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window